Apple News Facebook Twitter 新浪微博 Instagram YouTube Wednesday, Mar 15, 2023

Antiviral drug Remdesivir to be applied in clinical trials Thursday (2)

(Xinhua)    08:32, February 06, 2020


Professor Cao Bin, head of the antiviral drug Remdesivir's clinical trial program, speaks at a conference in Wuhan, central China's Hubei Province, Feb. 5, 2020. The registration for clinical trials on the antiviral drug Remdesivir has been approved, and the first batch of pneumonia patients infected by the novel coronavirus (2019-nCoV) are expected to start taking the drug on Thursday, according to an official conference Wednesday. (Xinhua/Cheng Min)


(For the latest China news, Please follow People's Daily on Twitter and Facebook)
(Web editor: Liang Jun, Bianji)

Add your comment

Most Read

Hot News

We Recommend


prev next